BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33158297)

  • 21. Chitosan-modified PLGA polymeric nanocarriers with better delivery potential for tamoxifen.
    Thakur CK; Thotakura N; Kumar R; Kumar P; Singh B; Chitkara D; Raza K
    Int J Biol Macromol; 2016 Dec; 93(Pt A):381-389. PubMed ID: 27586640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and in vitro testing of thermoresponsive polymer-grafted core-shell magnetic mesoporous silica nanoparticles for efficient controlled and targeted drug delivery.
    Peralta ME; Jadhav SA; Magnacca G; Scalarone D; Mártire DO; Parolo ME; Carlos L
    J Colloid Interface Sci; 2019 May; 544():198-205. PubMed ID: 30844568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Smart pH-responsive Nano-Carrier as a Drug Delivery System: A hybrid system comprised of mesoporous nanosilica MCM-41 (as a nano-container) & a pH-sensitive polymer (as smart reversible gatekeepers): Preparation, characterization and in vitro release studies of an anti-cancer drug.
    Abbaszad Rafi A; Mahkam M; Davaran S; Hamishehkar H
    Eur J Pharm Sci; 2016 Oct; 93():64-73. PubMed ID: 27497878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of facile drug delivery platform of ranibizumab fabricated PLGA-PEGylated magnetic nanoparticles for age-related macular degeneration therapy.
    Yan J; Peng X; Cai Y; Cong W
    J Photochem Photobiol B; 2018 Jun; 183():133-136. PubMed ID: 29704861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Facile Synthesis of Three Types of Mesoporous Silica Microspheres as Drug Delivery Carriers and their Sustained-Release Properties.
    Zhu Y; Wang B; Chen J; He J; Qiu X
    Curr Drug Deliv; 2023; 20(9):1337-1350. PubMed ID: 35713141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
    Zhang Q; Zhao H; Li D; Liu L; Du S
    Colloids Surf B Biointerfaces; 2017 Jan; 149():138-145. PubMed ID: 27750088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation and in-vitro evaluation of mesoporous biogenic silica nanoparticles obtained from rice and wheat husk as a biocompatible carrier for anti-cancer drug delivery.
    Porrang S; Rahemi N; Davaran S; Mahdavi M; Hassanzadeh B
    Eur J Pharm Sci; 2021 Aug; 163():105866. PubMed ID: 33957220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Redox and pH dual-responsive PEG and chitosan-conjugated hollow mesoporous silica for controlled drug release.
    Jiao J; Li X; Zhang S; Liu J; Di D; Zhang Y; Zhao Q; Wang S
    Mater Sci Eng C Mater Biol Appl; 2016 Oct; 67():26-33. PubMed ID: 27287095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thermo- and pH-responsive targeted lipid-coated mesoporous nano silica platform for dual delivery of paclitaxel and gemcitabine to overcome HER2-positive breast cancer.
    Nasri N; Saharkhiz S; Dini G; Yousefnia S
    Int J Pharm; 2023 Dec; 648():123606. PubMed ID: 37972671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid/PAA-coated mesoporous silica nanoparticles for dual-pH-responsive codelivery of arsenic trioxide/paclitaxel against breast cancer cells.
    Zhang BB; Chen XJ; Fan XD; Zhu JJ; Wei YH; Zheng HS; Zheng HY; Wang BH; Piao JG; Li FZ
    Acta Pharmacol Sin; 2021 May; 42(5):832-842. PubMed ID: 33824461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation and in vitro evaluation of doxorubicin-loaded Fe₃O₄ magnetic nanoparticles modified with biocompatible copolymers.
    Akbarzadeh A; Mikaeili H; Zarghami N; Mohammad R; Barkhordari A; Davaran S
    Int J Nanomedicine; 2012; 7():511-26. PubMed ID: 22334781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased Toxicity of Doxorubicin Encapsulated into pH-Responsive Poly(β-Amino Ester)-Functionalized MCM-41 Silica Nanoparticles.
    Ávila-Ortega A; Carrillo-Cocom LM; Olán-Noverola CE; Nic-Can GI; Vilchis-Nestor AR; Talavera-Pech WA
    Curr Drug Deliv; 2020; 17(9):799-805. PubMed ID: 32723272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation of a highly stable drug carrier by efficient immobilization of human serum albumin (HSA) on drug-loaded magnetic iron oxide nanoparticles.
    Hosseinpour Moghadam N; Salehzadeh S; Rakhtshah J; Hosseinpour Moghadam A; Tanzadehpanah H; Saidijam M
    Int J Biol Macromol; 2019 Mar; 125():931-940. PubMed ID: 30572041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pH dependent delivery of mesalazine from polymer coated and drug-loaded SBA-16 systems.
    Trendafilova I; Szegedi Á; Yoncheva K; Shestakova P; Mihály J; Ristić A; Konstantinov S; Popova M
    Eur J Pharm Sci; 2016 Jan; 81():75-81. PubMed ID: 26453768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and in vitro anti-cancer evaluation of tamoxifen-loaded magnetite/PLLA composite nanoparticles.
    Hu FX; Neoh KG; Kang ET
    Biomaterials; 2006 Nov; 27(33):5725-33. PubMed ID: 16890989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Galactosylated Chitosan-Functionalized Mesoporous Silica Nanoparticle Loading by Calcium Leucovorin for Colon Cancer Cell-Targeted Drug Delivery.
    Liu W; Wang F; Zhu Y; Li X; Liu X; Pang J; Pan W
    Molecules; 2018 Nov; 23(12):. PubMed ID: 30486276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Facile Layer-by-Layer Self-Assembly toward Enantiomeric Poly(lactide) Stereocomplex Coated Magnetite Nanocarrier for Highly Tunable Drug Deliveries.
    Li Z; Yuan D; Jin G; Tan BH; He C
    ACS Appl Mater Interfaces; 2016 Jan; 8(3):1842-53. PubMed ID: 26717323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Organically modified MCM-type material preparation and its usage in controlled amoxicillin delivery.
    Li Z; Su K; Cheng B; Deng Y
    J Colloid Interface Sci; 2010 Feb; 342(2):607-13. PubMed ID: 19948346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Preparation and stability of β-carotene loaded using mesoporous silica nanoparticles as carriers system].
    Liu J; Ren ZH; Wang HY; Jin XH
    Zhongguo Zhong Yao Za Zhi; 2015 Sep; 40(18):3579-84. PubMed ID: 26983203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation and characterization of Tamoxifen citrate loaded nanoparticles for breast cancer therapy.
    Maji R; Dey NS; Satapathy BS; Mukherjee B; Mondal S
    Int J Nanomedicine; 2014; 9():3107-18. PubMed ID: 25028549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.